• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎的自然病史:42例患者长达21年的随访研究。

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.

作者信息

Powell E E, Cooksley W G, Hanson R, Searle J, Halliday J W, Powell L W

机构信息

Department of Medicine, University of Queensland, Australia.

出版信息

Hepatology. 1990 Jan;11(1):74-80. doi: 10.1002/hep.1840110114.

DOI:10.1002/hep.1840110114
PMID:2295475
Abstract

Forty-two patients with nonalcoholic steatohepatitis were followed for a median of 4.5 yr (range = 1.5 to 21.5 yr). Except for two patients with lipodystrophy, all were obese; 35 of 42 were women, 26 of 32 were hyperlipidemic and 15 were hyperglycemic. Upper abdominal pain was the most common reason for presentation. Initial liver biopsy specimens showed the presence of macrovesicular fatty infiltration, lobular (acinar) inflammation, apoptosis, Mallory bodies (in four cases) and fibrosis (in 18 cases). Cirrhosis was present at initial diagnosis in one subject and in another two subjects liver biopsy showed marked fibrosis with disturbed architecture. Serial liver biopsy specimens revealed minimal or no apparent progression of the disorder in most of the patients, in keeping with their benign clinical course. However, one patient showed progression from fibrosis to cirrhosis during the 5-yr observation period, and in the patients with extensive fibrosis the liver disease evolved from one of active inflammation to one of inactive cirrhosis without fat or inflammation. The patient with cirrhosis later died of hepatocellular carcinoma. The severity or type of hepatic change did not correlate with the degree of obesity, hyperlipidemia or hyperglycemia. However, in individual patients, poorly controlled diabetes and rapid weight loss preceded the onset of steatohepatitis. We conclude that nonalcoholic steatohepatitis is a cause of hepatic inflammation histologically resembling that of alcohol-induced liver disease but usually slowly progressive and of low-grade severity. However, the disorder may ultimately result in cirrhosis. Nonalcoholic steatohepatitis should be distinguished from alcoholic steatohepatitis and recognized as a further cause of "cryptogenic cirrhosis."

摘要

42例非酒精性脂肪性肝炎患者接受了中位时间为4.5年(范围为1.5至21.5年)的随访。除2例脂肪代谢障碍患者外,其余均为肥胖者;42例中有35例为女性,32例中有26例血脂异常,15例血糖升高。上腹部疼痛是最常见的就诊原因。初始肝活检标本显示存在大泡性脂肪浸润、小叶(腺泡)炎症、凋亡、马洛里小体(4例)和纤维化(18例)。1例患者在初始诊断时即有肝硬化,另外2例患者肝活检显示有明显纤维化且结构紊乱。系列肝活检标本显示,大多数患者病情进展极小或无明显进展,与其良性临床病程相符。然而,1例患者在5年观察期内从纤维化进展为肝硬化,在广泛纤维化患者中,肝病从活动性炎症演变为无脂肪或炎症的非活动性肝硬化。肝硬化患者后来死于肝细胞癌。肝脏改变的严重程度或类型与肥胖、高脂血症或高血糖程度无关。然而,在个别患者中,糖尿病控制不佳和体重快速下降先于脂肪性肝炎发作。我们得出结论,非酒精性脂肪性肝炎是一种肝脏炎症的病因,其组织学表现类似于酒精性肝病,但通常进展缓慢且严重程度较低。然而,该疾病最终可能导致肝硬化。非酒精性脂肪性肝炎应与酒精性脂肪性肝炎相鉴别,并被视为“隐源性肝硬化”的另一个病因。

相似文献

1
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.非酒精性脂肪性肝炎的自然病史:42例患者长达21年的随访研究。
Hepatology. 1990 Jan;11(1):74-80. doi: 10.1002/hep.1840110114.
2
Two cases from the spectrum of nonalcoholic steatohepatitis.两例非酒精性脂肪性肝炎患者。
J Clin Gastroenterol. 1995 Mar;20(2):127-30. doi: 10.1097/00004836-199503000-00011.
3
Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.非酒精性脂肪性肝炎。门诊及住院患者中与酒精性肝炎的临床病理比较。
Dig Dis Sci. 1996 Jan;41(1):172-9. doi: 10.1007/BF02208601.
4
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝纤维化的独立预测因素
Hepatology. 1999 Dec;30(6):1356-62. doi: 10.1002/hep.510300604.
5
Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH).奥利司他可逆转肥胖非酒精性脂肪性肝炎(NASH)患者的脂肪浸润并改善肝纤维化。
Dig Dis Sci. 2007 Oct;52(10):2512-9. doi: 10.1007/s10620-006-9631-1. Epub 2007 Apr 3.
6
Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds.家族性非酒精性脂肪性肝炎和隐源性肝硬化
Am J Med. 2000 Jan;108(1):9-13. doi: 10.1016/s0002-9343(99)00315-0.
7
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.非酒精性脂肪性肝炎:梅奥诊所对一种此前未命名疾病的诊疗经验
Mayo Clin Proc. 1980 Jul;55(7):434-8.
8
Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.非酒精性脂肪性肝炎肝硬化肝移植后复发疾病。
Liver Transpl. 2009 Dec;15(12):1843-51. doi: 10.1002/lt.21943.
9
Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.非酒精性脂肪性肝炎的自然史:重复肝脏活检的纵向研究
Hepatology. 2004 Oct;40(4):820-6. doi: 10.1002/hep.20410.
10
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.纤维化严重程度是晚期非酒精性脂肪性肝病患者死因特异性死亡率的决定因素:一项多国队列研究。
Gastroenterology. 2018 Aug;155(2):443-457.e17. doi: 10.1053/j.gastro.2018.04.034. Epub 2018 May 5.

引用本文的文献

1
Changes After Leptin Administration in Partial Lipodystrophy and Factors Associated With Hepatic and Metabolic Response.瘦素给药后部分脂肪营养不良的变化以及与肝脏和代谢反应相关的因素。
J Endocr Soc. 2025 May 7;9(8):bvaf067. doi: 10.1210/jendso/bvaf067. eCollection 2025 Aug.
2
Social Determinants of Health Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-Analysis.与代谢功能障碍相关脂肪性肝病患病率及严重程度相关的健康社会决定因素:一项系统评价和荟萃分析
Am J Gastroenterol. 2025 Mar 17. doi: 10.14309/ajg.0000000000003421.
3
Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease.
髓系细胞触发受体2在非酒精性脂肪性肝病发病机制中的作用
World J Hepatol. 2025 Feb 27;17(2):102328. doi: 10.4254/wjh.v17.i2.102328.
4
Dietary Rhythms and MASLD-Related Hepatocellular Carcinoma.饮食节律与代谢相关脂肪性肝病相关肝细胞癌
Cancers (Basel). 2024 Oct 14;16(20):3481. doi: 10.3390/cancers16203481.
5
Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis.肝脏脂肪变性中MRI质子密度脂肪分数的评估:一项系统评价和荟萃分析。
Eur Radiol. 2025 Apr;35(4):1794-1807. doi: 10.1007/s00330-024-11001-1. Epub 2024 Sep 10.
6
AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases.基于人工智能的临床试验入组标准和终点评估自动化在肝脏疾病中的应用。
Nat Med. 2024 Oct;30(10):2914-2923. doi: 10.1038/s41591-024-03172-7. Epub 2024 Aug 7.
7
Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中果糖代谢的调节。
Biomolecules. 2024 Jul 13;14(7):845. doi: 10.3390/biom14070845.
8
Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis.肥胖非酒精性脂肪性肝炎儿童肝纤维化的血清学生物标志物
Pediatr Gastroenterol Hepatol Nutr. 2024 Jul;27(4):236-245. doi: 10.5223/pghn.2024.27.4.236. Epub 2024 Jul 8.
9
Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease.肝窦内皮细胞在代谢相关脂肪性肝病中的作用。
Cell Commun Signal. 2024 Jun 28;22(1):346. doi: 10.1186/s12964-024-01720-9.
10
Update on Imaging-based Noninvasive Methods for Assessing Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中基于成像的肝脂肪变性评估无创方法的最新进展
J Med Ultrasound. 2024 Apr 22;32(2):116-120. doi: 10.4103/jmu.jmu_88_23. eCollection 2024 Apr-Jun.